FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/102572 [Registered on: 30/01/2026] Trial Registered Prospectively
Last Modified On: 30/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Herbal Gel and Metformin Gel on Gum Health and Gum Blood Sugar Levels in Diabetic Patients With Gum Problems After Gums Treatment. 
Scientific Title of Study   Comparative Evaluation of Effectiveness of Momordica Charantia Gel and Metformin Gel As An Adjunct To Scaling and Root Planing on Gcf IL-6, TNF Alpha and Gingival Crevicular Blood Glucose level In Stage III Periodontitis With Type 2 Diabetes Mellitus -A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Archana Tekale  
Designation  PhD student  
Affiliation  Government Dental College and Hospital, Nagpur. 
Address  Dr Archana Tekale Nagrik, Government medical College buldana 443001

Nagpur
MAHARASHTRA
443001
India 
Phone  9422926275  
Fax    
Email  nagrik.archana83@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mangesh Phadnaik 
Designation  Professor and head of the department of periodontology. 
Affiliation  government dental college and hospital nagpur 
Address  Government dental college and hospital Nagpur, Maharashtra

Nagpur
MAHARASHTRA
440001
India 
Phone  9422254404  
Fax    
Email  drmbphadnaik@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mangesh Phadnaik 
Designation  professor and head of the department of periodontology. 
Affiliation  government dental college and hospital nagpur 
Address  government dental college and hospital, department of periodontivs, room no 217 Nagpur,

Nagpur
MAHARASHTRA
440001
India 
Phone  9422254404  
Fax    
Email  drmbphadnaik@gmail.com  
 
Source of Monetary or Material Support  
Government medical College and hospital, Buldana, Maharashtra.pin 443001 
 
Primary Sponsor  
Name  Dr Archana Tekale  
Address  Government medical College and hospital Buldana, Maharashtra 443001 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Archana Tekale  Government medical College and hospital Buldana   Dental department, Government mediacal college and Hospital Government Medical College and hospital Dental department,Buldana.
Buldana
MAHARASHTRA 
9422926275

nagrik.archana83@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Government dental college and hospital ,Nagpur Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-metformin1% metformin gel
2Comparator Arm (Non Ayurveda)-metformin1% metformin gel
3Comparator Arm (Non Ayurveda)-Metformin 1% metformin gel placed in gingival sulcus once only
4Intervention ArmDrugOther than Classical(1) Medicine Name: momordica charantia , Reference: NA, Route: Oral, Dosage Form: Lepa Churna, Dose: 1(g), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 1 Months, anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  patients with stage III periodontitis with controlled type II diabetes mellitis since 5 years with HbA1c levels , sites having probing depth of more than or equal to 6 mm, clinical attachment loss of more than or equal to 5mm, radiographic bone loss more than one third of the root. 
 
ExclusionCriteria 
Details  patients with medical disorders such as cardiovascular , renal, poorly controlled diabetes , liver disease , malignancy, radiotherapy. patients with recent history o or presence of acute or chronic infection. individuals with history of vtobacco chewing, smoking. pregnant woman or lactating mother. in ability of the person yo co operate because of their physical or mental in ability bor daily routine. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
gingival crevicular fluid levels of IL-6, TNF-Alpha and gingival crevicular blood glucose levels after treatment with metformin gel and momordica charantia gel in diabetes mellitis patients  At baseline and 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is planned to evaluate the effectiveness of momordica charantia herbal gel in comparison with metformin in class III Periodontitis patients having type II Diabetes Mellitis before and after scaling and root planning in gingival crevicular fluid comparing the presence of inflammatory markers . the study population is divided into three groups , and total 150 patients will be evaluated using single blind randomized controlled trial where the study subject will be blinded to the treatment assignment.  The inflammatory parameters will be assessed at baseline and three months, along with this clinical parameters like plaque index, gingival index, probing depth and clinical attachment levels will be assessed . 
Close